ACADIA Pharmaceuticals Inc (ACAD) — Long-term Investment Intensity
ACADIA Pharmaceuticals Inc (ACAD) has a Long-term Investment Intensity of 0.3% as of December 2019. Long-term investments of $2.30 Million represent 0.3% of total assets of $783.18 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check cash flow reinvestment rate of ACADIA Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
ACADIA Pharmaceuticals Inc Long-term Investment Intensity (2018–2019)
This chart shows how ACADIA Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2018 to 2019. As of December 2019, the intensity stands at 0.3%, reflecting long-term investments of $2.30 Million against total assets of $783.18 Million USD. Explore ACAD operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for ACADIA Pharmaceuticals Inc (2018–2019)
The table below presents the year-by-year Long-term Investment Intensity for ACADIA Pharmaceuticals Inc from 2018 to 2019, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see ACAD company net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 0.3% | $2.30 Million | $783.18 Million | ▲ +0.1 pp |
| 2018 | 0.2% | $1.30 Million | $540.20 Million | — |